New hope for Tough-to-Treat breast cancer: testing a powerful drug duo
Disease control
Not yet recruiting
This study is testing whether combining two drugs, elacestrant and trastuzumab deruxtecan, can help control advanced breast cancer that has grown despite prior hormone-based therapies. It will involve about 65 people with specific types of breast cancer (HR+/HER2-low or ultralow)…
Phase: PHASE1, PHASE2 • Sponsor: Sarah Sammons, MD • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC